Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Autor: Grinsztejn, Beatriz, Nguyen, Bach-Yen *, Katlama, Christine, Gatell, Jose M, Lazzarin, Adriano, Vittecoq, Daniel, Gonzalez, Charles J, Chen, Joshua, Harvey, Charlotte M, Isaacs, Robin D
Zdroj: In The Lancet 14-20 April 2007 369(9569):1261-1269
Databáze: ScienceDirect